Clinical Trials in San Antonio

Showing 4601-4620 of 14,633 trials

RECRUITING< 1 mile

Patient-derived Organoid Model and Circulating Tumor Cells for Treatment Response of Lung Cancer

NCT03655015

Create a living biobank of PDOs from Stage I-III lung cancer patients.

Lung Neoplasm

The University of Texas Health Science Center at San Antonio150 participantsStarted Oct 2018

San Antonio, Texas, United States

RECRUITINGPhase 1/2< 1 mile

A Study Evaluating the Safety and Efficacy of HB0036 in Subjects With Advanced Solid Tumors

NCT05417321

It is a Phase I/II, Open-label, Multicenter Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of HB0036 in Subjects with Advanced Solid Tumors

Advanced Solid TumorNSCLC

Shanghai Huaota Biopharmaceutical Co., Ltd.80 participantsStarted Aug 2022

Lafayette, Indiana, United States • San Antonio, Texas, United States • Spokane, Washington, United States +1 more locations

COMPLETEDNA< 1 mile

PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - S3 Intermediate

NCT03222128

The purpose of this trial is to determine the safety and effectiveness of the Edwards SAPIEN 3 transcatheter heart valve and delivery systems which are intended for use in patients with symptomatic, calcific, and severe aortic stenosis, and those with intermediate risk.

Symptomatic Severe Aortic Stenosis

Edwards Lifesciences1,074 participantsStarted Feb 2014

La Jolla, California, United States • Los Angeles, California, United States • Sacramento, California, United States +48 more locations

Patient-derived Organoid Model and Circulating Tumor Cells for Treatment Response of Lung Cancer

A Study Evaluating the Safety and Efficacy of HB0036 in Subjects With Advanced Solid Tumors

PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - S3 Intermediate

Find Trials by Condition in San Antonio

Phase III Double-blind, Placebo-controlled Study of AZD7442 for Pre-exposure Prophylaxis of COVID-19 in Adult.

A Study of the Efficacy and Safety of Ocrelizumab in Patients With Relapsing-Remitting Multiple Sclerosis

Kerecis Real-World Fish Skin Graft Registry

PATHFINDER 2: a Multi-Cancer Early Detection Study

A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease

Talimogene Laherparepvec With Pembrolizumab in Melanoma Following Progression on Prior Anti-PD-1 Based Therapy (MASTERKEY-115) (Mk-3475-A07/KEYNOTE-A07).

Safety and Efficacy of AIV001 on Scar Formation and Keloid Recurrence Following Keloidectomy

Study of AMG 994 Monotherapy and AMG 994 and AMG 404 Combination Therapy in Participants With Advanced Solid Tumors

Study to Measure Cerebrospinal Fluid Mutant Huntingtin Protein in Participants With Early Manifest Stage I or Stage II Huntington's Disease

VTX958 Versus Placebo for the Treatment of Active Psoriatic Arthritis (Tranquility-PsA)

Study to Assess the Safety of DERMASEAL for Diabetic Foot Ulcers

Evaluation of Buprenorphine Extended-Release Subcutaneous Injection at Alternative Injection Locations

A Safety Study of Pimavanserin in Adult and Elderly Subjects Experiencing Neuropsychiatric Symptoms Related to Neurodegenerative Disease

ANC-501 in the Treatment of Adults With Major Depressive Disorder

A Study to Investigate Efficacy and Safety of KBL697 in Patients with Moderate Plaque Type Psoriasis

A Phase I/II Study of AZD0466 as Monotherapy or in Combination With Anticancer Agents in Advanced Non-Hodgkin Lymphoma

Predictive Factors for Medullary Thyroid Cancer Aggressiveness